These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27241308)

  • 1. Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis.
    Faure G; Bakouh N; Lourdel S; Odolczyk N; Premchandar A; Servel N; Hatton A; Ostrowski MK; Xu H; Saul FA; Moquereau C; Bitam S; Pranke I; Planelles G; Teulon J; Herrmann H; Roldan A; Zielenkiewicz P; Dadlez M; Lukacs GL; Sermet-Gaudelus I; Ollero M; Corringer PJ; Edelman A
    J Mol Biol; 2016 Jul; 428(14):2898-915. PubMed ID: 27241308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR.
    Treharne KJ; Xu Z; Chen JH; Best OG; Cassidy DM; Gruenert DC; Hegyi P; Gray MA; Sheppard DN; Kunzelmann K; Mehta A
    Cell Physiol Biochem; 2009; 24(5-6):347-60. PubMed ID: 19910675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structure of Isoform CBd of the Basic Phospholipase A
    Nemecz D; Ostrowski M; Ravatin M; Saul F; Faure G
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
    Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
    Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the deltaF508 mutation: F508 deletion disrupts a kinase-binding site.
    Treharne KJ; Crawford RM; Xu Z; Chen JH; Best OG; Schulte EA; Gruenert DC; Wilson SM; Sheppard DN; Kunzelmann K; Mehta A
    J Biol Chem; 2007 Apr; 282(14):10804-13. PubMed ID: 17289674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.
    Chan KW; Csanády L; Seto-Young D; Nairn AC; Gadsby DC
    J Gen Physiol; 2000 Aug; 116(2):163-80. PubMed ID: 10919864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct.
    Lu M; Dong K; Egan ME; Giebisch GH; Boulpaep EL; Hebert SC
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6082-7. PubMed ID: 20231442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
    He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
    J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation.
    Chen X; Zhu S; Zhenin M; Xu W; Bose SJ; Wong MP; Leung GPH; Senderowitz H; Chen JH
    FASEB J; 2019 Apr; 33(4):5126-5142. PubMed ID: 30668920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
    Basso C; Vergani P; Nairn AC; Gadsby DC
    J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
    Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
    J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain.
    Odolczyk N; Fritsch J; Norez C; Servel N; da Cunha MF; Bitam S; Kupniewska A; Wiszniewski L; Colas J; Tarnowski K; Tondelier D; Roldan A; Saussereau EL; Melin-Heschel P; Wieczorek G; Lukacs GL; Dadlez M; Faure G; Herrmann H; Ollero M; Becq F; Zielenkiewicz P; Edelman A
    EMBO Mol Med; 2013 Oct; 5(10):1484-501. PubMed ID: 23982976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the ΔF508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator.
    Ravatin M; Odolczyk N; Servel N; Guijarro JI; Tagat E; Chevalier B; Baatallah N; Corringer PJ; Lukács GL; Edelman A; Zielenkiewicz P; Chambard JM; Hinzpeter A; Faure G
    J Mol Biol; 2023 Feb; 435(3):167929. PubMed ID: 36566799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.
    Mickle JE; Milewski MI; Macek M; Cutting GR
    Am J Hum Genet; 2000 May; 66(5):1485-95. PubMed ID: 10762539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of the cystic fibrosis transmembrane conductance regulator protein.
    Frizzell RA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S54-8. PubMed ID: 7533606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.
    Cui L; Aleksandrov L; Hou YX; Gentzsch M; Chen JH; Riordan JR; Aleksandrov AA
    J Physiol; 2006 Apr; 572(Pt 2):347-58. PubMed ID: 16484308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.
    Li C; Ramjeesingh M; Reyes E; Jensen T; Chang X; Rommens JM; Bear CE
    Nat Genet; 1993 Apr; 3(4):311-6. PubMed ID: 7526932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity analysis of a CFTR channel potentiator: Distinct molecular parts underlie dual gating effects.
    Csanády L; Töröcsik B
    J Gen Physiol; 2014 Oct; 144(4):321-36. PubMed ID: 25267914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.